Article
Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Journal of gastroenterology and hepatology - 1 Feb 2010
Chen Li-Wei, Chien Rong-Nan, Yen Cho-Li, Chang Jia-Jang, Liu Ching-Jung, Lin Chih-Lang
Abstract excerpt
BACKGROUND AND AIM: Occult hepatitis B virus (HBV) infection is defined by the detectable serum HBV-DNA in HBV surface antigen-negative patients. This retrospective study aims to evaluate the therapeutic effects of combined pegylated interferon (PEG-IFN) plus ribavirin (RBV) in patients with concurrent occult HBV/hepatitis C virus (HCV) dual infection. METHODS: In total, 126 consecutive chronic hepatitis C (CHC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
